Open AccessP1188: PERSONALIZED TREATMENT ACCORDING TO BIOLOGICAL PROFILE IMPROVES OUTCOME OF NEWLY DIAGNOSED PATIENTS AFFECTED BY DIFFUSE LARGE B‐CELL LYMPHOMA: A REAL‐LIFE EXPERIENCE
Author(s) -
Guidetti A.,
Pasquale R.,
Dodero A.,
Chiappella A.,
Devizzi L.,
Farina L.,
Rusconi C.,
Pennisi M.,
Corradini P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847616.32906.58
Subject(s) - medicine , diffuse large b cell lymphoma , oncology , rituximab , bcl6 , lymphoma , vincristine , hematology , progression free survival , cyclophosphamide , chemotherapy , immunology , b cell , antibody , germinal center